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ABSTRACT
BACKGROUND: Although ultrasonography was 
introduced into Obstetrics and Gynaecology by a British 
Gynaecologist over five decades ago, the requirement 
for formal training in its use by gynecologists in Nigeria 
is just beginning to catch on, despite its indispensible 
role in various aspects of our clinical practice.  
OBJECTIVE: To describe the role of ultrasonography 
in in-vitro fertilization and the indispensability of the 
instrument to reproductive medicine.
METHOD: A review of literature written in English 
language on the use and application of ultrasonography 
in in-vitro fertilization was done.  The review covered 
articles published between 1980-2012.
RESULTS: Ultrasound is the most versatile method for 
pre-treatment assessment in IVF being the dominant 
instrument for assessing ovarian reserve, pelvic 
pathologies and for assessing the uterine cavity. The 
ability of ultrasonography to measure endometrial 
thickness in addition to detecting uterine masses gives it 
an edge over laparoscopy/hysteroscopy as a diagnostic 
procedure in uterine cavity assessment, although 
hysteroscopy has the advantage of therapeutic potential. 
Similarly, ultrasonography is superior to biochemical 
methods for follicular monitoring because of its ability 
to demonstrate the number and sizes of follicles, and 
guide preparations for oocyte retrieval. The relative ease 
of ultrasound guided oocyte retrieval; its less technical 
demands and the possibility of conducting the procedure 
under local anaesthesia have made ultrasound guided 
oocyte retrieval more popular across the world. 
Randomized controlled trials show that ultrasound-
guided transfer techniques have better outcomes than 
the clinical touch technique in terms of on-going 
pregnancies and clinical pregnancies. Ultrasonography 
is now the key instrument for diagnosing and monitoring 
pregnancy following embryo transfer, biochemical 
methods being complimentary.
CONCLUSION: Ultrasonography is now the single 
most important instrument in in-vitro fertilization 
programmes and gynaecologists with interest in 
reproductive medicine need necessarily to obtain a 
formal training in its use.
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INTRODUCTION
Context 
There is concern over the development of ultrasound 
practices in Obstetrics and Gynaecology in developing 
countries especially in Nigeria because of its increasing 
availability and the need to promote high standards in its 
practice. There is no doubt that radiologists and 
radiographers with special training in obstetric and 
gynaecological ultrasonography could be important 
personnel in an ultrasound practice within Obstetrics 
and Gynaecology departments, exactly how much 
responsibility should be devolved by gynaecologists to 
these groups has not been defined. To underline the need 
for formal training in ultrasonography by 
obstetrician/gynaecologists, the Royal College of 
Obstetricians and Gynaecologists (RCOG) recently 
liaised with the Society and College of Radiographers 
(SCoR) of the UK and the British Medical Ultrasound 
Society (BMUS) to institute a new competency-based 
ultrasound training programme that forms a compulsory 
part of the curriculum for doctors undergoing speciality 
1training in obstetrics and gynaecology.   One 
subspecialty where ultrasound training is particularly 




Infertility is defined as the inability of a couple to 
achieve a pregnancy after one year of unprotected well-
2
timed sexual intercourse . Worldwide infertility affects 
10-14 % of couples and one in seven couples in the UK 
3, 4has infertility . Infertility is described as primary when 
a woman has never achieved a pregnancy before or 
secondary when the woman had achieved a pregnancy 
before irrespective of the outcome of the pregnancy. The 
causes of infertility can be traceable to the woman in 
about 40-50% of cases, the man in 35%-40 of cases, both 
in 15-20% and in 10% of cases, the cause of the 
3
infertility remains unknown after all investigations . 
Compared to developed countries, developing countries 
are thought to have higher prevalences of infertility due 
to higher prevalences of genital infections including 
sexually transmitted pelvic inflammatory disease, 
postpartum infections and post abortal infections in the 
5
developing world . However, according to The 
European Society for Human Reproduction and 
Embryology, it is thought that more couples in 
developed countries are developing infertility due to 
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factors such as obesity, smoking and delaying of first 
6pregnancy resulting in ovarian ageing . The treatment of 
infertility can take any form from simple processes such 
as ovulation induction or antibiotic therapy to more 
complex and invasive procedures like tubal surgery and 
assisted reproductive technology (ART).
 Assisted Reproductive Technology  
The international committee for monitoring Assisted 
Reproductive Technology and the World Health 
Organization (WHO) define ART as” all treatments and 
procedures that include the in-vitro handling of both 
human oocytes and sperm, or embryos, for the purpose 
of establishing a pregnancy” and state that ART does not 
7
include artificial insemination . The WHO estimates, 
that about 10% of infertile couples in any nation would 
8need assisted reproduction procedure . For the purpose 
of this review, we adopt the WHO definition of ART. 
Accordingly, types of assisted reproductive techniques 
will include in-vitro fertilization and embryo transfer 
(IVF-ET), gamete intra-fallopian transfer (GIFT), 
zygote intra-fallopian transfer (ZIFT), intracytoplasmic 
sperm injection and pre-implantation genetic diagnosis 
7
(PGD) .
The indications for assisted reproductive techniques 
have expanded over time since the first attempts of ART 
for tubal disease and now include conditions such as 
endometriosis, severe oligozoospermia, azoospermia, 
unexpla ined infer t i l i ty ,  previous  b i la tera l  
9salpingectomy, bilateral vasectomy etc . However, 
irrespective of the indication, in-vitro fertilization and 
embryo transfer can be done to overcome the problem of 
9infertility .
In-vitro Fertilization and Embryo Transfer
IVF-ET is a sequential procedure. The key steps involve 
preliminary assessment of the uterine cavity, 
superovulation induction by hormonal manipulation, 
aspiration of the mature follicle, sperm washing and 
treatment (capacitation), incubation of the ova and 
sperm in a special medium, transfer of fertilized ova into 
the endometrial cavity for implantation to occur, and 
monitoring the developing pregnancy. Factors 
associated with success in IVF-ET include the age of the 
woman, the duration of infertility and the technique of 
10transfer . Current practices and guidelines on IVF-ET 
aim at maintaining a high standard of professional and 
5, 6 
ethical practice at every step of the process . Although 
guidelines are in agreement as to what steps need to be 
taken during IVF-ET, some steps in IVF-ET can be 
undertaken through more than one technique. With 
advancement in medical technology, refinements in 
various alternative procedures continue to emerge. The 
basis for choosing one method in preference to the other 
should be determined by the availability of evidence of 
superiority. Alternative methods are available at each of 
the major steps of IVF-ET such as pre-treatment uterine 
c a v i t y  a s s e s s m e n t  ( h y s t e r o s c o p y  v e r s u s  
Ultrasonography), egg retrieval (laparoscopic guidance 
versus ultrasound guidance) and embryo transfer 
5, 6
(ultrasound guidance versus clinical touch technique  .
SOURCES OF LITERATURE 
The information contained in this review were obtained 
through  electronic  literature search conducted in major 
data bases including PubMed, Medline, EMBASE, 
Scopus, Google scholar, Cochrane database and  central 
register of controlled trials using the following search 
terms individually and in combination: infertility, 
assisted reproduction technology, in-vitro fertilization, 
embryo transfer, ultrasonography, uterine cavity 
assessment, follicular monitoring, superovulation 
induction, follicular tracking, oocyte retrieval, early 
pregnancy monitoring, ultrasonography in IVF-ET. All 
relevant peer-reviewed English language articles and 
publications were identified, retrieved and reviewed. 
We also obtained further articles by reviewing the 
bibliographies of the relevant published documents 
obtained in the primary search of databases. In addition 
to these, we consulted the website of the International 
Federation of Gynaecology and Obstetrics (FIGO) and 
the European Society for Human Reproduction and 
Embryology (ESHRE). 
HISTORY OF IVF AND ULTRASONOGRAPHY
There are many parallel reports of the historical 
development of in-vitro fertilization in different parts of 
the world, especially the United Kingdom, the United 
States and Australia. The first human IVF attempt was 
reported by Rock and Menkin in the United States in 
1944, but the attempt ended with no convincing 
11
evidence of fertilization . In 1963, R. G. Edwards began 
his research on the human egg in the United Kingdom 
and in 1965 published his first paper on in-vitro 
maturation of human ovarian oocytes and was able to 
calculate the moment of human ovulation necessary to 
11plan retrieval of the eggs in a timely fashion . The first 
pregnancy achieved through in-vitro fertilization of a 
human oocyte was reported in The Lancet by the 
Monash University team in 1973, although it lasted only 
a few days and was essentially a biochemical pregnancy. 
An ectopic pregnancy following IVF-ET was reported 
12
by Steptoe and Edwards in 1976 . These earlier studies 
preceded the landmark achievement of 1978 by Steptoe 
12and Edwards of first live birth by in-vitro fertilization . 
It must be said that the development of ART coincided 
with the development of ultrasonography and 
ultrasound was to be deployed as a tool for the conduct 
of key steps in in-vitro fertilization from its early years.
Ian Donald is widely credited with the introduction of 
ultrasonography into Obstetrics and Gynaecology, 
although ultrasound had been in use for several decades 
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before his foray into experiments on the use of ultrasonic 
metal flaw detector to distinguish between fibroid 
masses and ovarian cysts excised during surgery in 1955 
13. He later published his results in The Lancet of 7 June 
1958 under the title 'Investigation of Abdominal Masses 
13 
by Pulsed Ultrasound' . Ultrasound in Gynaecology 
started as a diagnostic tool in the differentiation and 
assessment of solid, cystic or solid masses in the pelvis 
and one of the earliest uses of ultrasonography in 
Gynaecology was in monitoring the development of 
ovarian follicles during superovulation in in-vitro 
14
fertilization . In 1976, Hackloer and Hansmann 
reported a successful monitoring of ovarian follicular 
size and number in patients undergoing ovulation 
13
induction, using a full bladder as a sonic window .  
Ultrasound monitoring was formally introduced into 
ovulation induction programmes in 1979 and by 1980-
1982, a number of important reports had attested to the 
usefulness of abdominal ultrasound in the assessment of 
13follicular development and ovulation . Colm O'Herlihy 
and Australian co-workers published a paper on 
important follicular size criterion and protocols for 
13ovulation induction .
Transvaginal scans were introduced in the mid-1980s 
and the addition of endometrial evaluation using 
transvaginal scan enhanced diagnostic accuracies in the 
13management of ovulation cycles . Interventional 
sonography in Gynaecology dates back to the early 
1970s when Hans Henrik Holm described percutaneous 
15
puncture of ovarian tumors in 1972 . In 1982, David 
Graham and Roger Sanders revisited the idea of 
transvaginal aspiration of pelvic masses under trans 
16
abdominal ultrasound guidance . There was necessity 
to develop similar techniques for the retrieval of ovarian 
follicles in in-vitro fertilization programmes which had 
hitherto been achieved only through laparoscopy. Susan 
Lenz and JG Lauritsen described percutaneous trans 
abdominal- transvesical aspiration of ovarian follicles in 
1982 and 1983 which showed for the first time that ovum 
retrieval could be performed as an ultrasound guided 
17, 18
outpatient procedure .  Transvaginal ovum retrieval 
under trans abdominal guidance was described by 
Gleicher in Chicago in1982 and in 1984 by Dellenbach 
19-21
and co-workers in France . The advantage of this 
technique is that ovaries are more accessible and the 
procedure is safer and relatively pain-free. More 
importantly, the procedure is repeatable on an outpatient 
basis and it dramatically cut down the cost of IVF 
procedures. In 1985, Kemeter and Feichtinger described 
the use of transvaginal aspiration of follicles under 
21-23transvaginal ultrasound guidance . Stuart Campbell's 
group at Kings College London was among one of the 
earliest pioneering groups to have set up an out-patient 
13oocyte retrieval service in IVF .  Color Doppler was 
introduced in the mid-1980s about the same time as 
transvaginal probe. Tom Bourne and colleagues were 
among the first to document the usefulness of peri-
ovulatory blood flow in ovarian and uterine arteries in 
13
the management of assisted reproductive cycles . With 
improvements in ultrasonic and computer technology, 
work on three-dimensional visualization began to 
appear in the early 1980's. In gynecological 
applications, Davor Jurkovic at Kings College London 
convincingly demonstrated in 1995 the usefulness of 3-
D ultrasound in accurately differentiating uterine 
13anomalies such as bicornuate uterus and septate uteri . 
Similarly the assessment of the endometrial cavity with 
3-D sonohysterography and characterization of 
endometrial masses, adhesions, tubo-ovarian masses, 
hydrosalpinges, ovarian cysts, small intraovarian 
tumours and mullerian anomalies have all been quickly 
13
and convincingly demonstrated . 
THE ROLE OF ULTRASONOGRAPHY 
PRE-TREATMENT ASSESSMENT
Pre-treatment assessment of women prior to IVF 
involves assessment of ovarian reserve, identification of 
adnexal pathology and uterine pathology especially 
uterine cavity with a view to identifying any factor that 
can impair the success of IVF.  Ovarian reserve is 
defined as the number and quality of the remaining 
24, 25ovarian follicular pool at any given time . The aim of 
assessing ovarian reserve is to identify those women 
likely to respond poorly to ovulation induction, those 
who have a low chance of success, those who are more 
likely to have their treatment cycle cancelled and those 
prone to ovarian hyperstimulation, which is associated 
25
with significant morbidity and even mortality . The 
assessment of ovarian reserve is often made indirectly 
through serum measurement of follicle-stimulating 
hormone (FSH) during the early follicular phase of the 
cycle or the endocrine factors produced by the 
developing follicles, including estradiol, inhibin B, and 
25-27
anti-Mullerian hormone (AMH) . Ovarian reserve 
may also be assessed directly using ultrasound, which 
can be used to quantify the total number of antral 
follicles, mean ovarian volume and ovarian vascularity 
28-31. All of these tests have different sensitivities, 
specificities and predictive values, but there is a lack of 
consensus as to the best single test or combination of 
32
tests . Although, basal FSH is the most widely used 
marker of ovarian reserve worldwide, ultrasound 
assessment strongly complements this by directly 
33
demonstrating the availability of antral follicles .
Ultrasound is the very useful for identifying pelvic 
pathologies associated with aberrant and compromised 
outcomes during IVF, including polycystic ovarian 
disease, moderate and severe degrees of endometriosis 
(often characterised by rectovaginal disease and the 
presence of ovarian endometrioma), fibroids, 
34-40
endometrial polyps and tubal disease . Functional 
cysts can interfere with treatment and can enlarge 
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following down regulation treatment or secrete 
oestrogen and progesterone, which can prevent or delay 
34
successful pituitary desensitisation . Pre-treatment 
ultrasound may also reveal complex multiloculated 
cysts containing thick-walled septae suggestive of 
34malignancy, which require removal . The diagnosis of 
hydrosalpinx can generally be made using transvaginal 
35
ultrasound with a high degree of confidence . 
Pre-treatment uterine cavity assessment is based on the 
belief that a healthy endometrium is a pre-requisite for 
implantation to occur following natural fertilization or 
34
artificial fertilization and embryo transfer . Diseases 
and conditions interfering with endometrial integrity 
such as submucous fibroids, endometrial polyps, 
hormonal imbalance, endometritis and endometrial 
41-47
fibrosis with synechia can all impair implantation .
The methods applied for uterine cavity assessment 
include ultrasonography, hysterocontrastsonography 
( H y C o S y ) ,  s a l i n e  h y s t e r o s o n o g r a p h y ,  
hys t e ro sa lp ingog raphy  and  hys t e ro scopy .  
Hysterosalpingography has poor reproducibility, is 
expensive, involves ionizing radiation and can be quite 
painful and is therefore not considered first choice for 
48assessing the uterine cavity .  Whereas hysteroscopy 
allows inspection of the uterine cavity under direct 
vision, it is thought to be invasive and expensive and 
49may necessitate the use of anaesthesia . Hysteroscopy 
however has the advantage of being both diagnostic and 
potentially therapeutic as lesions such as polyps, 
adhesive bands and submucous fibroids can be excised 
49
under direct vision . In addition, hysteroscopy is 
thought to have a better sensitivity, specificity, negative 
and positive predictive values in distinguishing between 
14normal and abnormal endometrium . Transvaginal 
ultrasonography is less invasive and allows for 
measurement of endometrial thickness which is a 
valuable index for estimating the degree of luteinization 
50-52
of the endometrium . Saline hysterosonography is a 
modification of transvaginal scanning in which saline 
solution is instilled into the uterine cavity during 
transvaginal ultrasound scanning to help delineate 
lesions such as polyps. It allows for easier diagnosis of 
polyps and submucous fibroids than plain ultrasound 
14
scan  .
It would therefore appear that with respect to 
pretreatment uterine cavity assessment, there appears to 
42be little clarity with respect to the preferable technique , 
53. No randomized controlled studies comparing 
hysteroscopy versus ultrasonography is available. 
Current practice appears to favour a choice between 
ultrasound based assessments (transvaginal scan, saline 




Monitoring follicular development during controlled 
ovarian stimulation can be done biochemically by assay 
of serum estrogen or by ultrasound examination of 
increasing sizes of developing follicles- a process often 
9, 41
referred to as follicular tracking  . The monitoring 
process is intended to enable the physician to choose the 
most suitable protocol, to obtain best possible outcome, 
9, 34
and to avoid complications  . Monitoring therefore 
allows for the determination of the optimal time for the 
administration of human chorionic gonadotropin to 
mimic the luteinizing hormone surge of natural cycles in 
order to minimize the incidence and severity of ovarian 
34hyperstimulation syndrome (OHSS) . The first blood 
test and ultrasound scan are usually done approximately 
8 days after starting the FSH injections and the 
combined results are used to decide the ideal time for 
9
egg retrieval .  Administration of human chorionic 
gonadotrophin for follicular maturation is done at 
ovarian follicular diameter of 18-20mm and endometrial 
9
thickness of 8-10mm . Aspiration of oocytes is done 
about 37 hours following the administration of the 
9human chorionic gonadotropin .
 A recent Cochrane review found only two randomized 
controlled trials to determine the effect of monitoring 
stimulated cycles with estrogen assay plus 
 54, 55
ultrasonography versus ultrasonography alone . The 
review concluded that there was no evidence that 
monitoring with estrogen and transvaginal ultrasound 
was superior to ultrasound alone in terms of pregnancy 
rates and live births but recommended that cycle 
monitoring by transvaginal ultrasound plus serum 
estradiol may need to be retained as a precautionary 
good practice point. However, the current practice is 
tilting towards the use of ultrasound scan alone in 
follicular and endometrial thickness tracking as against 
 56, 57
its combination with serum estradiol monitoring .
OOCYTE RETRIEVAL
With respect to oocytes retrieval, no recent studies have 
been done and evidence available dates back to the 
1980s.There are no recent randomized controlled 
studies comparing laparoscopy with ultrasound guided 
aspiration. A number of comparative observational 
studies done in the late eighties showed that there was no 
significant differences between the outcomes of IVF-ET 
with laparoscopic oocytes retrieval compared to oocytes 
aspiration under ultrasound guidance either 
transvaginally, trans urethrally or transvesically. Lewin 
and colleagues early in 1986 randomized 120 women to 
ultrasound guided aspiration and laparoscopy and found 
58
similar clinical pregnancy rates . In a study in Norfolk, 
England, Flood and co-workers also showed no 
statistically significant differences with respect to total 
number of follicles aspirated per cycle, preovulatory 
oocytes aspirated per cycle, number of concepti of 
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preovulatory origin transferred per cycle between 
59 laparoscopic and ultrasound-guided procedures . They 
concluded that ultrasound guided aspiration was 
comparable to laparoscopy and should be the method of 
choice. In a study in Yugoslavia, Tomazevic and 
colleagues compared 105 cycles of ultrasound guided 
retrieval with 218 cycles of laparoscopic retrieval and 
also concluded that ultrasound retrieval was simpler, 
60
less painful and should be preferred . Several 
comparative studies done in the late 1980s reached 
61-65similar conclusions .
Despite the lack of evidence from randomized 
controlled studies, there is sufficient evidence from 
comparative non-randomized studies to show that 
ultrasound guided oocyte retrieval is easier,   less 
technically demanding and cheaper than laparoscopic 
34
approach .  The possibility of conducting the procedure 
under local anaesthesia has made ultrasound guided 
retrieval more popular among IVF centres across the 
world.
EMBRYO TRANSFER
During embryo transfer, embryos are replaced into the 
uterine cavity, through a trans-cervical transfer catheter, 
at the 4-8-cell stage (between days 2 to 5) of 
9development . Traditionally, the "clinical touch" 
method has been used to guide placement of the transfer 
catheter to within 10 mm from the uterine fundus prior to 
9injection of the embryos . This method is essentially 
"blind" and relies on the clinician's tactile senses to 
judge when the transfer catheter is in the correct position 
10. Some clinicians transfer the embryos at a fixed 
distance from the external os (6cm), however this may 
not take into account variation in cervical length or 
9, 34uterine size, or position . 
Numerous methods to improve the technique of embryo 
transfer have been studied to try and improve pregnancy 
rates, including changing the type of catheter used, 
performing a trial or "mock" transfer before the actual 
procedure, encouraging bed rest following embryo 
66, 67
transfer .
Embryo transfer has been the subject of many 
randomized controlled trials and at least four systematic 
reviews between 2003 and 2012 including two 
68-78Cochrane reviews in 2007 and 2010 . Results have 
been conflicting with respect to the relative advantage of 
ultrasound-guided transfer method over the clinical 
touch method of embryo transfer. In the most recent 
Cochrane Systematic Review update in which 17 
randomized trials were selected out of potential 52, the 
authors found that  “although clinical pregnancies and 
ongoing pregnancies were increased for the ultrasound 
guided group compared with the clinical touch group; 
there was no evidence of a difference between 
ultrasound guided embryo transfer and clinical touch for 
the outcome of live birth. The risks of harm using 
ultrasound guided transfer, including miscarriage, 
ectopic pregnancies and multiple pregnancies, are no 
different to when clinical judgment is used.” 
EARLY PREGNANCY MONITORING
Following a successful embryo transfer, the developing 
pregnancy needs to be monitored to determine its 
9
viability and eventual location . Two methods are used 
for this monitoring. These are serum B-hCG and 
9ultrasonography . Biochemical pregnancy can be 
detected by a positive pregnancy test as early as 4 weeks 
following implantation, although a false positive test at 
this stage may result from the gonadotropin 
administered as luteal support prior to follicular 
9
aspiration . With respect to biochemical testing, serum 
pregnancy test is preferred because it is more sensitive 
than urine pregnancy test. However, a negative serum 
pregnancy test at 2 weeks after embryo transfer does not 
completely exclude a pregnancy.   and co-
th
workers posited that single serum â hCG on 12  day after 
embryo transfer has a comparable result with serial 
79serum â hCG on the diagnosis of pregnancy .
Ultrasonography can detect a beating embryonic heart 
9as early as 5weeks plus 2 days .  The detection of a 
visible heart beat on ultrasound is an absolute sign of an 
ongoing pregnancy. With the advent of transvaginal 
ultrasonography (TVUS), the diagnosis of pregnancy 
can be made even earlier than is feasible with trans-
9
abdominal ultrasonography (TAUS) . Mid-luteal 
endometrial thickness of = 11 mm was found to be a 
good prognostic factor for detecting early pregnancy by 
58
Sholan and colleagues . TVUS is preferred to TAUS 
during early pregnancy for reasons including the fact 
that it can detect signs of intrauterine pregnancy 
approximately 1 week earlier than TAUS; patients do 
not require to have a full bladder and are not required to 
endure uncomfortable pressure on the abdominal wall 
from the abdominal probe; pelvic organs are far better 
9, 80imaged by TVUS in obese patients . The major 
disadvantage of TVUS is that some patients are anxious 
about the transvaginal probe and may object to its 
80insertion . 
The earliest structure identified with TVUS is the 
gestational sac (GS) at 4-5 weeks gestation and the GS 
80grows at a rate of 1 mm/d in early gestation . By 5.5-6 
weeks' gestation, a double-decidual sign can be seen, 
which is the Gestational Sac surrounded by the 
80thickened decidua . The ultrasound scan is also used to 
detect the number of gestation and calculate age of 
80
pregnancy . The foetal cardiac motion is detected at 5-6 
80
weeks . All these facts make ultrasonography 
unarguably the most useful and precise tool for early 
pregnancy detection and subsequent monitoring.
 Bjercke
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SUMMARY
Ultrasonography is a key instrument in any in-vitro 
fertilization programme. It is the most versatile single 
instrument for pre-treatment assessment. Its ability to 
measure endometrial thickness in addition to detecting 
u t e r i n e  m a s s e s  g i v e s  i t  a n  e d g e  o v e r  
laparoscopy/hysteroscopy, although the ability of the 
later to offer curative procedures suggest that facilities 
for both ultrasonography and hysteroscopy are needed 
for the initial assessment. Ultrasonography is the 
method of choice for monitoring the growth and 
development of ovarian follicles during controlled 
ovarian stimulation. Ultrasound has also become the key 
instrument for egg retrieval. Randomized controlled 
trials show that ultrasound-guided transfer techniques 
result in higher on-going and clinical pregnancy rates 
compared to the clinical touch technique .  
Unquestionably, ultrasonography is the key instrument 
for diagnosing and monitoring pregnancy following 
embryo transfer.
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